Nanomedicines in the European translational process

Nanomedicines in the European translational process Abstract In 2013, the World Health Organisation (WHO) released an update of the report on “Priority Medicines for Europe and the World” with the aim to bridge the gap between public health needs and the current research and development priorities. A number of emerging technologies are currently explored for their potential to respond to the identified unmet medical needs. Nanotechnology has the potential to offer scientific/technical solutions for some of these pharmaceutical gaps. The present report investigates to what extent projects funded by the European Commission will lead to innovative formulations as well as new therapeutic concepts, if clinical studies in European Member States investigating nanomedicines and finally if nanotech based products authorised in the European Union will contribute to identified public health needs. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Nanomedicine de Gruyter

Nanomedicines in the European translational process

Loading next page...
 
/lp/de-gruyter/nanomedicines-in-the-european-translational-process-RRFhRJCsIN
Publisher
de Gruyter
Copyright
Copyright © 2015 by the
ISSN
1662-5986
eISSN
1662-596X
D.O.I.
10.1515/ejnm-2015-0027
Publisher site
See Article on Publisher Site

Abstract

Abstract In 2013, the World Health Organisation (WHO) released an update of the report on “Priority Medicines for Europe and the World” with the aim to bridge the gap between public health needs and the current research and development priorities. A number of emerging technologies are currently explored for their potential to respond to the identified unmet medical needs. Nanotechnology has the potential to offer scientific/technical solutions for some of these pharmaceutical gaps. The present report investigates to what extent projects funded by the European Commission will lead to innovative formulations as well as new therapeutic concepts, if clinical studies in European Member States investigating nanomedicines and finally if nanotech based products authorised in the European Union will contribute to identified public health needs.

Journal

European Journal of Nanomedicinede Gruyter

Published: Jun 1, 2015

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off